ECM
Endurant Capital Management Portfolio holdings
AUM
$17.4M
1-Year Return
4.95%
This Quarter Return
-2.06%
1 Year Return
+4.95%
3 Year Return
+16.8%
5 Year Return
+58.39%
10 Year Return
–
AUM
$268M
AUM Growth
-$59.5M
(-18%)
Cap. Flow
-$51.2M
Cap. Flow
% of AUM
-19.11%
Top 10 Holdings %
Top 10 Hldgs %
44.52%
Holding
92
New
17
Increased
19
Reduced
32
Closed
23
Top Buys
| 1 |
Universal Health Services
UHS
|
$9.88M |
| 2 |
Abbott
ABT
|
$7.99M |
| 3 |
Johnson & Johnson
JNJ
|
$6.83M |
| 4 |
Becton Dickinson
BDX
|
$6.28M |
| 5 |
Elevance Health
ELV
|
$4.74M |
Top Sells
| 1 |
Danaher
DHR
|
$9.04M |
| 2 |
McKesson
MCK
|
$8.53M |
| 3 |
TVTY
Tivity Health, Inc. Common Stock
TVTY
|
$7.85M |
| 4 |
VanEck Biotech ETF
BBH
|
$6.22M |
| 5 |
Sabra Healthcare REIT
SBRA
|
$6.16M |
Sector Composition
| 1 | Healthcare | 93.35% |
| 2 | Real Estate | 1.88% |
| 3 | Financials | 1.53% |
| 4 | Technology | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Cigna
CI
$81.5B
| $3.46M | 1.29% |
20,600
+18,600
| +930% | +$3.12M |
|
|
EVHC
27
DELISTED
Envision Healthcare Holdings Inc
EVHC
| $3.16M | 1.18% |
82,174
-114,000
| -58% | -$4.38M |
|
|
CELG
28
DELISTED
Celgene Corp
CELG
| $2.86M | 1.07% |
32,000
-5,800
| -15% | -$517K |
|
|
TVTY
29
DELISTED
Tivity Health, Inc. Common Stock
TVTY
| $2.41M | 0.9% |
60,819
-197,938
| -76% | -$7.85M |
|
|
PTLA
30
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
| $2.34M | 0.87% |
71,500
-36,100
| -34% | -$1.18M |
|
|
WMGI
31
DELISTED
Wright Medical Group Inc
WMGI
| $2.24M | 0.84% |
113,072
-192,128
| -63% | -$3.81M |
|
|
KA
32
DELISTED
Kineta, Inc. Common Stock
KA
| $2.24M | 0.84% |
3,372
-92
| -3% | -$61.2K |
|
33
Baxter International
BAX
$12.5B
| $2.17M | 0.81% |
33,349
-16,900
| -34% | -$1.1M |
|
|
HRC
34
DELISTED
HILL-ROM HOLDINGS, INC.
HRC
| $2.12M | 0.79% |
24,400
-41,800
| -63% | -$3.64M |
|
|
35
Danaher
DHR
$143B
| $2.08M | 0.78% |
23,987
-104,114
| -81% | -$9.04M |
|
|
OXFD
36
DELISTED
Oxford Immunotec Global PLC Ordinary Shares
OXFD
| $2.06M | 0.77% |
165,169
-405,256
| -71% | -$5.04M |
|
37
Amicus Therapeutics
FOLD
$2.46B
| $1.91M | 0.71% |
127,000
-79,400
| -38% | -$1.19M |
|
38
Masimo
MASI
$8B
| $1.84M | 0.69% |
+20,900
| New | +$1.84M |
|
|
CLVS
39
DELISTED
Clovis Oncology, Inc.
CLVS
| $1.75M | 0.65% |
33,100
-34,550
| -51% | -$1.82M |
|
40
Puma Biotechnology
PBYI
$253M
| $1.68M | 0.63% |
24,700
-5,200
| -17% | -$354K |
|
|
41
McKesson
MCK
$85.5B
| $1.62M | 0.61% |
11,523
-60,577
| -84% | -$8.53M |
|
42
Incyte
INCY
$16.9B
| $1.62M | 0.6% |
19,420
+12,000
| +162% | +$1,000K |
|
43
Fate Therapeutics
FATE
$116M
| $1.52M | 0.57% |
155,344
-401,335
| -72% | -$3.92M |
|
44
VanEck Pharmaceutical ETF
PPH
$622M
| $1.45M | 0.54% |
+25,500
| New | +$1.45M |
|
45
Revvity
RVTY
$10.1B
| $1.44M | 0.54% |
19,041
+9,636
| +102% | +$730K |
|
46
Cardinal Health
CAH
$35.7B
| $1.41M | 0.53% |
22,542
-79,229
| -78% | -$4.97M |
|
47
Bausch Health
BHC
$2.72B
| $1.36M | 0.51% |
+85,200
| New | +$1.36M |
|
48
Agilent Technologies
A
$36.5B
| $1.34M | 0.5% |
+20,000
| New | +$1.34M |
|
49
Quest Diagnostics
DGX
$20.5B
| $1.3M | 0.49% |
+13,000
| New | +$1.3M |
|
|
ARRY
50
DELISTED
Array Biopharma Inc
ARRY
| $1.17M | 0.44% |
71,400
+20,800
| +41% | +$339K |
|